Recent events
Recent events tied to this brand in public sources.
Back to profile9 entries
2026
McKesson and a private equity firm acquire home infusion company Option Care Health
Managed Healthcare Executive reports that McKesson, together with a private equity firm, has bought home infusion company Option Care Health.
2026
McKesson and Clayton Dubilier & Rice in advanced talks to jointly acquire Option Care Health
Following a Financial Times report, shares of Option Care Health surged more than 20% in premarket trading. The report said health care services company McKesson and private equity firm Clayton Dubilier & Rice are in advanced talks to jointly acquire the infusion services provider in a transaction valued at more than $5 billion. McKesson stock rose 1.5%.
2021
Former employee sued McKesson alleging racial discrimination
A former McKesson employee filed a lawsuit alleging that the company discriminated against him on the basis of race. He claims that African American employees were terminated over sample-account use while non-African American team members who also used the account were not terminated. The allegations are claims in the lawsuit.
2021
McKesson raises FY2022 earnings guidance
McKesson raised its fiscal 2022 adjusted earnings-per-share guidance to $22.35–$22.95, from its previous range of $21.95–$22.55. The company said the revised guidance reflects an additional $0.40 related to the federal government's Covid-19 vaccine distribution program.
2021
New York reaches $1.1 billion opioid settlement with distributors
New York agreed to a $1.1 billion settlement with Cardinal Health, McKesson and AmerisourceBergen over claims that they helped fuel the opioid epidemic. The agreement requires the distributors to create a clearinghouse of opioid shipments to help flag suspicious orders.
2020
Oklahoma sues opioid distributors
Oklahoma Attorney General Mike Hunter filed a lawsuit against Cardinal Health, McKesson and AmerisourceBergen, alleging that the companies distributed an oversupply of opioids into Oklahoma. The companies' liability is alleged, not established in the report.
2019
Michigan sues opioid distributors under state drug-dealer law
The state of Michigan filed a lawsuit against Walgreens, Cardinal Health, McKesson Corporation, and AmerisourceBergen Drug Corporation under the Michigan Drug Dealer Liability Act. The state alleged that the distributors facilitated the illegal opioids market and failed to monitor or report suspicious orders; the companies denied the allegations.
2019
Michigan sues Walgreens and drug distributors over opioid crisis
Michigan filed a lawsuit against McKesson Corporation, Cardinal Health Inc., AmerisourceBergen Corporation, and Walgreens. The suit charges them with contributing to the opioid epidemic by flooding the market with prescription pain pills and selling the drugs without oversight, allowing diversion for illegal use.
2019
Michigan sued four companies over the opioid epidemic
Michigan sued AmerisourceBergen, Cardinal Health, McKesson, and Walgreens over the opioid epidemic. Michigan Attorney General Dana Nessel alleged that the companies distributed controlled substances in the state without controls; the complaint sought damages related to the crisis.